In this interview, Dr. Jonathan Meyer discusses practical considerations when prescribing psychotropic medications for patients with hepatic issues. He emphasizes the use of the Child-Pugh Score in determining how hepatic impairment can affect drug metabolism and the need for subsequent dosing adjustments. He also clarifies dosing considerations for specific medications, such as clozapine, olanzapine, and valproate, in the context of patients with hepatic issues.
- Provider:Medical Academy, LLC
- Activity Link: https://psychopharmacologyinstitute.com/publication/use-of-psychotropics-in-patients-with-hepatic-issues-interview-2655?utm_source=PARS+ACCME&utm_medium=PARS+ACCME&utm_campaign=PARS+ACCME
- Start Date: 2022-05-01 05:00:00
- End Date: 2022-05-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Performance
- Provider Ship: Jointly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest